Goldstein Dov A MD

Goldstein Dov A MD is listed in filings as Chief Financial Officer at BioAge Labs, Inc.. This profile follows SEC Form 4 activity through Apr 24, 2026, including sale activity. Recent filings connect the profile to BioAge Labs, Inc. (BIOA), Coya Therapeutics, Inc. (COYA), and Gain Therapeutics, Inc. (GANX). The current snapshot covers public activity from Jun 26, 2024 to Apr 24, 2026. Reported amounts are shown as $15.5K to $239.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.